source
- AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicineNewly published data convinced AstraZeneca to conduct a sprawling late-stage program for its GLP-1 pill. Elsewhere, Bausch + Lomb will lay off 119 employees and Cartesian boosted its ‘in vivo’ cell…BioPharma Dive · 2mo ago↗ source
- DOJ reaches second settlement on youth gender careA new era of American sunscreen, NIAID taps new acting director, and more health news from Morning RoundsSTAT · 2mo ago↗ source
- Are Republicans turning against medications for treating opioid addiction?Federal actions and proposals have reignited debate over methadone and buprenorphine, worrying addiction experts and patient groups.STAT · 2mo ago